International Biotechnology
data as at: 28/05/2020| Company website | |
| Objective | To achieve capital growth through investing in high growth, development stage biotechnology companies. |
| Management group | SV Health Managers |
| AIC sector | Biotechnology & Healthcare |
| Launch date | 06/05/1994 |
| Financial year end | August |
| Domicile | United Kingdom |
Please note, some investment companies release their Net Asset Values (NAVs) less frequently than daily. For example they may provide NAVs on a weekly, monthly, quarterly or even semi-annual basis. This means that the estimated NAV shown below, and the associated discount/premium to market price, will not necessarily reflect recent market movements.
| Total assets (m) | Price (last close) | Price (bid) | Price (offer) | NAV | Dividend dates | Discount/ premium (%) | Gearing (%) | 5yr dividend growth (%) p.a. | Dividend yield (%) |
|---|---|---|---|---|---|---|---|---|---|
| 294.7 | 768.00 | 768.00 | 772.00 | 768.26 | Jul, Dec | 0.0 | 2 | N/A | 3.2 |
Dividends
Dividends displayed in traded currency.
| Ex-Dividend Date | Dividend amount | Dividend type | Special dividend | Financial year |
|---|---|---|---|---|
| 19/12/2019 | 12.400 | Capital | No | 2020 |
| 18/07/2019 | 14.000 | Capital | No | 2019 |
| Dividend cover (years) | Revenue reserves (m) |
|---|---|
| N/A | -38.76 |
Trading information
| ISIN | TIDM | Traded currency |
|---|---|---|
| GB0004559349 | IBT | GBX |
Traded volumes (number of shares)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 58,314 | 2,494,103 | 18,680,870 | 71,857,684 |
| Average | N/A | 122,538 | 73,554 | 56,222 |
Traded values (m)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 0.45 | 17.93 | 116.19 | 416.71 |
| Average | N/A | 0.88 | 0.46 | 0.33 |
Data provided by Morningstar. Company documents provided by Financial Express. 
